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Serum vitamin D and IgE levels in infants and children under 2 years of age with 
recurrent chest wheeze 
 
INTRODUCTION 
Wheezing is a very common complaint on 
admission to the pediatric emergency department 
and it is one of the most common causes of 
morbidity and mortality worldwide1.Thirty percent 
of children have at least one wheezing attack before 
the age of three, and 50% before the age of six. It 
has been reported that recurrent wheezing attacks 
might frequently be seen before school-age and 
40% of children with recurrent wheezing attacks 
can suffer from wheezing symptoms later in life2. 
The relationship between wheezing in infancy and 
ensuing development of asthma has been under 
investigation for a long time. There is also detailed 
research determining the risk factors of recurrent 
wheezing3. 
Vitamin D (VD) is a vital nutrient obtained 
either through endogenous production in the skin 
with exposure to ultraviolet B radiation or from 
dietary sources. It acts as a hormone and is well-
known for its role in calcium and phosphorus 
homeostasis and skeletal health4. There is an 
increasing awareness of the important role of VD in 
the maintenance of the immune system and 
respiratory health5,6. The diseases traditionally 
associated with VD deficiency are rickets and 
osteomalacia, but growing data suggests that VD 
plays an important role in the lung development and 
vitamin D deficiency may be a risk factor for 
asthma, recurrent wheezing and respiratory 
infections7-10. The exact association between VD 
levels and recurrent wheezing is not obvious11. 
There are a few studies investigating the 
relationship between recurrent wheezing and VD 
levels and these studies reported the association 
between maternal VD intake and early infant 
wheezing12,13. 
Although the impact of VD on the immune 
system is controversial, some researchers have 
claimed that the beneficial effects of stimulating 
VD pathway include decreased inflammation and 
enhanced defense against pathogens7,9,14-16. VD is 
recognized as an important modulator of both the 
innate and adaptive immune system 17. Increased 
susceptibility to infections, asthma, atopy, recurrent 
wheeze and reduced lung volume was noticed in 
patients with VD deficiency18-21. 
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VD deficiency has been largely attributed to 
dietary, lifestyle and behavioral changes during 
recent decades22, 23 especially in Western Countries. 
Both children, pregnant and lactating women are 
identified as groups vulnerable to VD deficiency24 . 
Moreover, both low maternal VD intake during 
pregnancy and low umbilical cord blood VD levels 
have been associated with increased risk of 
childhood wheezing12, 25. 
The possibility that immune mechanisms may 
contribute to the beginning of wheeze has been 
supported by studies that tend to favor an IgE 
mediated hypersensitivity type26. Some authors 
have found higher total IgE levels in young children 
with persistent wheezing27. A prospective 
population study has also shown that children with 
early sensitization and persistent wheezing had high 
IgE levels throughout childhood28. Growing 
evidence suggests role for VD in the regulation of 
IgE and the development of allergic sensitization29.  
Hence this study was conducted to: measure serum 
25 hydroxy vitamin D (25OHD) and total IgE 
levels in infants and children under 2 years of age 
who presented with recurrent wheeze in comparison 
to healthy controls. To assess the risk factors for 
recurrent wheeze during this age period and 
investigate whether subnormal levels of 25OHD 
were associated with increased risk for recurrent 
wheeze. To investigate the relation between the 
studied parameters and the number of wheeze 
attacks and hospitalization in patient group. 
 
METHODS 
Study design and population 
This single-center case control study was carried 
out in Assiut University Pediatric Hospital. The 
investigational protocol was approved by the local 
Ethical Committee of Medical School of Assiut 
University. Parents of all patients and controls gave 
their informed consents and written approvals for 
their children's participation before their enrollment 
in the study. 
The study group consisted of 85 infants (58 
males and 27 females), with a physician-diagnosed 
recurrent wheezing (>3 attacks) and had been 
admitted to the Pediatric Emergency Department. 
Inclusion criteria were; aged 6-24 months, normal 
growth and development consistent with age, no 
use of systemic or inhaled steroid during or just 
prior to the study, no history of other disease that 
could be related with wheezing. The diagnosis, 
severity and control level of wheezing were 
assessed in compliance with GINA criteria30. 
Exclusion criteria were; prematurity 
(<37weeks), low birth weight (<2500 gram), history 
of NICU admission with RD, history of intubation 
and assisted ventilation during the neonatal period; 
patients who had an underlying cardiopulmonary, 
immunodeficiency, neurologic or metabolic 
diseases, or any chronic disorder. Further exclusion 
criteria were current infection, malnutrition and VD 
supplementation in the last 3 months. 
The control group included 85 age- and gender-
matched healthy infants randomly recruited from 
the Well Child Outpatient Clinic during their 
regular follow-up. They had no instance of chest 
wheeze, chronic disease or chest deformity; no 
diagnosed atopic dermatitis, allergic rhinitis or 
urticaria; no food or drug allergy; no diagnosed 
liver disease; no instances of lower respiratory tract 
infection in the last 3 months; no history of 
infection in the last 2 weeks; and no long-term 
supportive VD treatment in the last 3 months. 
Each parent was informed about wheezing and 
was asked whether their infant had had this before, 
and if yes, how often. The wheezy infant was 
accepted as having >3 wheezing attacks with no 
known reason within the previous 6 months. The 
discrimination of wheezing was carried out in 
accordance with the advice of the European 
Respiratory Society Task Force.31 
Parents of all cases and controls were asked to 
complete the same standardized questionnaire after 
face-to-face interviews. The questionnaire 
examined the patients' address and birth details; the 
family’s socioeconomic conditions; the presence of 
asthma, allergic rhinitis, and eczema; presence of 
risk factors for wheezing, how many wheezing 
attacks they had, admission to emergency 
department in the last 6 months, consanguinity, 
contact with house birds and pets, passive smoking 
exposure, birth information, type of feeding during 
first 6 months and VD supplementation. 
Full physical examination was carried out for all 
patients and controls with recording of the vital 
signs, patients’ height, weight and BMI. 
 
Sample collection and laboratory investigations: 
Sample collection: 5ml of venous blood were 
collected from all patients and controls under 
standardized conditions after a fasting period of at 
least 4 hours. Two ml of blood were drawn on 
K3EDTA for complete blood count using the 
Coulter counter technique.  (Coulter Hmx 
USA).The other portion of blood (3ml)was drawn 
in plain tubes, centrifuged (3,000 g for 10 min.) and 
the separated serum samples were divided and 
stored in aliquots at –20 ºC until the day of analysis. 
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Assays for serum biomarkers: 
Assay of serum 25OHD levels were done using 
EIA Kit from Immune diagnostic AG Bensheim, 
Germany, Ref.K2110. The results are expressed in 
nmol/L. According to the manufacturer's 
instructions of the Kit used, VD concentrations 
>75nmol/l are sufficient, from 30-75 nmol/l are 
insufficient, while <30nmol/l are seriously 
deficient. Assay of serum IgE levels was done using 
EIA from Bio-Check, USA, catalog no BC 1035. 
The results are expressed in IU/ml. 
 
Statistical Methods 
Clinical and laboratory data were statistically 
analyzed using a computer program (SPSS 16 for 
Windows). We calculated proportions and 
percentages for qualitative variables and means and 
standard deviations for quantitative variables. Chi 
test, independent sample t-test, ANOVA and 
Pearson correlation and their non-parametric 
equivalents were used to test significant 
associations. We determined univariate associations 
between risk factors and the outcome of recurrent 
wheeze attacks using the Pearson Ç2 test for 
categorical variables and simple ordinal logistic 
regression for ordinal variables. Log transformation 
was performed to normalize data with skewed 
distribution. All of the P values are 2-tailed, with 




Table 1. Socio-demographic characteristics of patients and controls. 
 





Age# (Mean ±SD): 0.98 ±0.16 0.97 ±0.08 0.554* 0.581 








-Females 27 (31.8) 33 (38.8)  








-Rural/Slum 61 (71.8) 57(67.1)  
#Log transformation for age in months was performed to normalize the distribution then independent sample t-test was used. 
* t- value of the independent sample t-test. 
 
Table 2. Comparison of serum 25 OHD and total IgE levels, and eosinophil and WBC counts of the patient 
and control groups. 
 
Variables Patients Controls P-value§ 95% CI 
-WBC (1000/mm3) 11.1± 3.8 11.4 ± 4.4 0.92 -1.515-1.00419 
-Eosinophil count (cells/mm3) 343 ± 366 143 ±160 0.0001* 113.65-284.96 
-Total IgE(IU/mL) 154.1±37.3 23.4±4.9 0.0001* 58.301-203.219 
-25OHD(nmol/L) 59.8± 23.9 108.3 ± 45.8 0.0001* -59.473-37.445 
§ Mann-Whitney Test was used as data was not normally distributed. 
* Significant    -Values are expressed as Mean ± SD. 
 
 
Table 3. VD statuses of patients and controls. 
 
VD levels (nmol/L) 
Cases 
No. / (%) 
Controls 
No. /  (%) 
P-value* 
-Seriously deficient 12   (14.1) 00   (00.0) 
0.00001 
-Insufficient 48   (56.5) 28   (32.9) 
-Sufficient 25  (29.4) 57   (67.1) 
-Total 85   (100) 85    (100) 
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Table 4. The relation between the investigated parameters and the number of hospitalizations of 
the patient group. 
 








None .030* .337 .008* .112 
Once .001* .236 .000* .608 
2-3 .002* .232 .381 .084 
2-3 times 
None .151 .013* .037* .000* 
Once .757 .003* .000* .169 
Once None .087 .026* .071 .014* 
§ Log transformation for cell counts and biomarkers was performed to normalize the data distribution then one way 





Table 5. The correlation of the investigated parameters to the number of wheeze attacks 






-Vitamin D (nmol/L) - 0.4 .0001* 
-IgE(IU/mL) 0.3 .0001* 
-Eosinophils(cells/mm3) 0.2 0 .035* 
-WBC (1000/mm3) 0.08 0.2 








*spearman correlation was performed. *spearman correlation was performed. 
  
Figure 1. Correlation between serum 25OH D levels 
and number of wheeze attacks in the study group. 
Figure 2. Correlation between serum 25OHD levels 
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DISCUSSION 
There are few studies investigating the relationship 
between recurrent wheezy chest and VD levels. The 
current study aimed to estimate serum VD and IgE 
levels in infants and children less than 2 years of 
age with recurrent wheeze and to investigate 
whether subnormal levels of VD are associated with 
increased risk for recurrent wheeze. 
We found that serum VD levels were 
significantly lower in infants with recurrent wheeze 
than in healthy controls (P= 0.0001). These findings 
are in agreement with those of Soner et al,4 who 
recommended that infants with recurrent wheezing 
should be scanned for VD insufficiency and they 
speculated that the duration of VD supplementation 
could be extended, especially for infants who had 
been diagnosed with recurrent wheezing during the 
first year of their life. 
Also in consistent with the results of our study, 
Katarina et al,17evaluated the risk factors for acute 
wheeze in preschool children and investigated 
whether subnormal levels of VD were associated 
with increased risk for acute wheeze. They found 
that preschool children with acute wheeze had 
significantly lower VD levels than healthy controls. 
Many other studies also concur that VD deficiency 
is associated with non-infectious wheezing illnesses 
in children3, 32, 34. Other studies failed to prove this 
relationship 11, 33. Özaydın, et al 11 could not find any 
relationship between serum VD levels and recurrent 
wheeze probably due to the small sample size of 
their study.  
A similar observation was reported from the 
United States, where no association was found 
between VD levels and exacerbations in asthmatic 
children, although asthma was more severe in those 
with VD insufficiency32. Moreover, Hibbs, et al.14 
mentioned that there are some potential 
mechanisms by which VD supplementation may 
increase wheezing, and postulated that exposing the 
immature immune system to VD may predispose to 
asthma and allergy later in life.  
Among the studied patients, 14.1% had serum 
25OHD levels <30 nmol/L (seriously deficient), 
and 56.5% had levels from 30-70 nmol/L 
(insufficient) whereas in healthy controls, none had 
serum VD levels <30 nmol/L and 32.9% were VD 
insufficient Hence, the patient group had a 
significantly higher proportion of infants with 
seriously deficient and insufficient serum VD levels 
than controls (P=0.00001 for both). Abdulbari et 
al.35 found 23.4% of wheezy children and 10.5% of 
healthy children severely VD deficient. Moreover, 
they found nearly half (48.6%) of their healthy 
children mildly VD deficient. They concluded that 
VD deficiency is highly prevalent even in sun-
replete areas of the world and that VD 
supplementation and fortification of foods were 
inadequate to prevent its deficiency. 
The possibility that immune mechanisms may 
contribute to the beginning of wheeze has been 
supported by studies that tend to favor an IgE 
mediated hypersensitivity type of mechanism.26 
Growing evidence suggests a role for VD in the 
regulation of IgE and the development of allergic 
sensitization.29 In this study, serum IgE levels and 
eosinophil counts of patient group were 
significantly higher than those of healthy controls 
(p<0.0001 for both). Moreover, VD correlated 
significantly and negatively with serum IgE levels 
(R= -331, P=0.0001). Brehm et al.34 reported a 
similar relationship and found that each 10-ng/mL 
increase in VD resulted in a 25-IU/mL decrease in 
IgE levels for asthmatic infants. Soner et al.4, 
however, found a positive linear relationship in their 
patients’ group but a negative, albeit insignificant 
one, (log10) in their control group, . They attributed 
this to the insufficient number of their controls and 
postulated that VD and IgE have a strict interaction 
with each other. 
In this study, the relationships between the 
studied parameters (serum 25OHD, IgE and WBC 
& eosinophil counts) and the number of wheeze 
attacks and hospitalizations were investigated in the 
patient group. Serum VD levels showed highly 
significant negative correlation with the number of 
wheeze attacks indicating that VD deficiency 
having a significant role in the recurrence of 
wheezy chest in those patients.   
This is consistent with Metin et al.3 who found 
significant relationship between recurrence and 
temporal pattern of wheeze with serum VD. It has 
also been reported that there is an association 
between VD deficiency and the number of asthma 
attacks in children with asthma36. In agreement with 
our results, some studies have shown a relationship 
between lower VD levels and hospitalization3. A 
large cohort study for children with asthma in Costa 
Rica showed an association between low VD levels 
and asthma severity in terms of hospitalizations, 
medication use and airway responsiveness34. 
However, a study from Canada failed to show this 
relationship37. 
Our study showed lower serum VD levels in 
infants with recurrent wheeze than in healthy 
controls. VD insufficiency was common in the 
study group whereas severe VD deficiency was 
significantly higher in infants with recurrent 
wheeze than in healthy controls. Therefore, this 
study provides additional evidence supporting a 
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role of VD in wheezing infants. It may be useful 
that all infants with recurrent wheezing be scanned 
for VD insufficiency. The role of VD 
supplementation in the control of recurrent infant 
wheeze awaits randomized controlled clinical trials. 
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